reversed-phase HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-02-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or below | For the lyophilised powder, desiccated |
| Storage form | Sealed vial, protected from light | Amber glass or foil-wrapped containers |
| Reconstituted stability | Short, refrigerate | Degradation accelerates in solution |
| Typical analytical method | Reversed-phase HPLC with mass spectrometry | Purity assessment plus identity confirmation |
| Common synonyms | Melanotan II, MT-II | Also written melanotan-2 |
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Reported observations after unregulated use include shifts in skin pigmentation and, in some accounts, unintended changes to moles and other lesions. Whether these outcomes are causally linked to the compound, and how often they occur, remain open questions because controlled data are scarce. The absence of standardised dosing and verified product purity complicates interpretation. Researchers have called for better surveillance and analytical characterisation of samples obtained outside regulated channels. Conclusions drawn from anecdotal evidence should be treated as provisional.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
== Structure == The thermodynamically stable form of CaCO3 under normal conditions is hexagonal β-CaCO3 (the mineral calcite). Other forms can be prepared, the denser (2.83 g/cm3) orthorhombic λ-CaCO3 (the mineral aragonite) and hexagonal μ-CaCO3, occurring as the mineral vaterite. The aragonite form can be prepared by precipitation at temperatures above 85 °C; the vaterite form can be prepared by precipitation at 60 °C. Calcite contains calcium atoms coordinated by six oxygen atoms; in aragonite they are coordinated by nine oxygen atoms. The vaterite structure is not fully understood. Magnesium carbonate (MgCO3) has the calcite structure, whereas strontium carbonate (SrCO3) and barium carbonate (BaCO3) adopt the aragonite structure, reflecting their larger ionic radii.
A venipuncture is useful as it is a minimally invasive way to obtain cells and extracellular fluid (plasma) from the body for analysis. Blood flows throughout the body, acting as a medium that provides oxygen and nutrients to tissues and carries waste products back to the excretory systems for disposal. Consequently, the state of the bloodstream affects or is affected by, many medical conditions. For these reasons, blood tests are the most commonly performed medical tests. If only a few drops of blood are needed, a fingerstick is performed instead of a venipuncture. Indwelling arterial, central venous and peripheral venous lines can also be used to draw blood. Phlebotomists, laboratory practitioners and nurses are those in charge of extracting blood from a patient. This can be done in-clinic, in-office, or through mobile (home) phlebotomists. However, in special circumstances, and/or emergency situations, paramedics and physicians extract the blood. Also, respiratory therapists are trained to extract arterial blood to examine arterial blood gases.
She works with several biopharmaceutical companies to apply new mass spectrometry techniques to new drug modalities including monoclonal antibodies. She also develops new mass spectrometry instrumentation. Her group looks at the structure of biological systems at a molecular level, studying them in the gas and solution phase as well as theoretically. They use electrospray ionization, mass spectrometry, ion mobility mass spectrometry native mass spectrometry and complementary solution based biophysical techniques. They are interested in a proteins structure and how it changes in an effort to relate that to their function. Ion-mobility spectrometry–mass spectrometry can be used to look at the temperature dependent rotationally averaged collision cross-section of gas-phase ions of proteins. In 2014 she was awarded a Biotechnology and Biological Sciences Research Council grant to study the interactions of proteins with other proteins. Barran serves on the editorial board of the International Journal of Mass Spectrometry. She was included in the page of Perditas created by Perdita Stevens.
=== FRIDOC database === FRIDOC is the most comprehensive database in the world dedicated to refrigeration. It contains over 110,000 references to documents in all domains of refrigeration. A large number of the documents referenced in FRIDOC are scientific and technical. FRIDOC also contains many review articles, documents on economic data and statistics, articles dealing with regulations and standardisation, etc.
==== Invasion of Iraq ==== Planning for the Operation Iraqi Freedom began in December 2001; in 2002 several teams of 10th SFG and CIA SAD operatives were infiltrated into Iraqi Kurdistan in advance of hostilities. They were based in the Harir valley outside Irbil and tasked to develop ground truth intelligence while organising and training the Peshmerga; they were also there to monitor Ansar al-Islam and plan for a future operation against them. For the 2003 invasion of Iraq, CJSOTF-West (Combined Joint Special Operations Task Force-West/Task Force Dagger) was formed around the 5th SFG, their ODAs were tasked with two core missions: the first – to counter the SCUD TELs and by denying the Iraqi military the use of potential launch sites and the second – provide both intelligence-gathering and screening function in support of conventional forces to build up an accurate picture of Iraqi force dispositions in western Iraq. The Green Beret ODAs were deployed under the command and control of ODBs (Operational Detachment Bravo) which operated as roving AOBs (Advanced Operating Bases), these AOBs provided a mobile resupply function using their modified M1078 Light Medium Transport Vehicles which meant that the ODA patrols could operate for extended periods in enemy territory before linking up with a fighting patrol that would be escorting the AOBs for combat resupply.
Sources: en.wikipedia.org
11B Infantryman (includes soldiers formerly designated 11M [Mechanized] and 11H [Anti-armor]) 11B Infantryman is the basic infantry soldier MOS of the US Army. 11C Indirect Fire Infantryman (Mortarman) 11X Undetermined Infantry (Open Enlistment Option, B/C determined during training.) 11Z Infantry Senior Sergeant
== Mechanism of action == Chemically, naloxegol is a pegylated (polyethylene glycol-modified) derivative of α-naloxol. Specifically, the 6-α-hydroxyl group of α-naloxol is connected via an ether linkage to the free hydroxyl group of a monomethoxy-terminated n=7 oligomer of PEG, shown extending at the lower left of the molecule image at right. The "n=7" defines the number of two-carbon ethylenes, and so the chain length, of the attached PEG chain, and the "monomethoxy" indicates that the terminal hydroxyl group of the PEG is "capped" with a methyl group. The pegylation of the 6-α-hydroxyl side chain of naloxol prevents the drug from crossing the blood–brain barrier (BBB).
=== Other appearances === "TV Eye" with Wylde Ratttz, Velvet Goldmine: Music from the Original Motion Picture, 1999. "Elephant Love Medley" with Nicole Kidman, Moulin Rouge! Music from Baz Luhrmann's Film, 2001. "El Tango de Roxanne" with Jose Feliciano, Moulin Rouge! Music from Baz Luhrmann's Film, 2001. "Your Song" with Alessandro Safina, Moulin Rouge! Music from Baz Luhrmann's Film, 2001. "Here's To Love" with Renée Zellweger, Down With Love: Music from and Included in the Motion Picture, 2003. "The Sweetest Gift", Unexpected Dreams – Songs From the Stars, 2006. "Be Our Guest" with Emma Thompson, Ian McKellen, and Gugu Mbatha-Raw, Beauty and the Beast, 2017. "Days in the Sun" with Adam Mitchell, Stanley Tucci, Ian McKellen, Emma Thompson, Emma Watson, Audra McDonald, Clive Rowe, Beauty and the Beast, 2017. "Something There" with Emma Watson, Dan Stevens, Ian McKellen, Emma Thompson, Nathan Mack, Gugu Mbatha-Raw, Beauty and the Beast, 2017. "The Mob Song", with Luke Evans, Josh Gad, Emma Thompson, Ian McKellen, Stanley Tucci, Nathan Mack, & Gugu Mbatha-Raw, Beauty and the Beast, 2017. "Better Tomorrows", Pinocchio, 2022.
Timber can be dried to any desired low moisture content by conventional or solar kiln drying, but in air drying, moisture contents of less than 18% are difficult to attain for most locations. The drying times are considerably less in conventional kiln drying than in solar kiln drying, followed by air drying. This means that if capital outlay is involved, this capital sits for a longer time when air drying is used. On the other hand, installing, operating and maintaining an industrial kiln is expensive. In addition, wood that is being air dried takes up space, which could also cost money. In air drying, there is little control over the drying conditions, so drying rates cannot be controlled. The temperatures employed in kiln drying typically kill all the fungi and insects in the wood if a maximum dry-bulb temperature of above 60°C is used for the drying schedule. This is not guaranteed in air drying. If air drying is done improperly (exposed to the sun), the rate of drying may be overly rapid in the dry summer months, causing cracking and splitting, and too slow during the cold winter months. Significant advantages of conventional kiln drying include higher throughput and better control of the final moisture content. Conventional kilns and solar drying both enable wood to be dried to any moisture content regardless of weather conditions. For most large-scale drying operations solar and conventional kiln drying are more efficient than air drying. Compartment-type kilns are most commonly used in timber companies.
The proposed formation of a UN "verification mission" to monitor Cuba's adherence to a withdrawal settlement proved instrumental in persuading the South African government that it would receive a balanced agreement. The talks began progressing more smoothly after July 1988, when Carlos Aldana Escalante was appointed head of the Cuban delegation. Aldana was chief of ideological affairs and international relations for the Communist Party of Cuba; he was far better informed of foreign developments, particularly in the Soviet bloc, than many of his contemporaries. In light of Gorbachev's reforms, political developments in Eastern Europe, and the reduction of tensions between the superpowers, Aldana believed that Cuba needed to work swiftly towards normalising relations with the US. Cooperation vis-à-vis Southern Africa was seen as a natural prerequisite to better relations with Washington and possibly, a permanent bilateral dialogue. Between May and September 1988, the parties met for several rounds of talks in Cairo, New York, Geneva, and Brazzaville, but remained deadlocked on the nuances of the withdrawal timetable. The fact that there were two objectives—Namibian independence and a Cuban withdrawal—doubly aggravated the issue of timing and deadlines. In August, the Angolan, Cuban, and South African delegations signed the Geneva Protocol, which established the principles for a peace settlement in South West Africa and committed the SADF to a withdrawal from that territory. As a direct result of the Geneva Protocol, PLAN declared a ceasefire effective from 10 August.
Sources: en.wikipedia.org
The lyophilised solid is best kept cold, dry and dark, typically at minus twenty degrees Celsius. Moisture and repeated warming cycles are the main causes of degradation. Solutions prepared from the powder are less stable and are normally used quickly.
Reversed-phase liquid chromatography assesses purity, while mass spectrometry confirms molecular mass and detects sequence errors. Amino acid analysis and peptide mapping add structural detail. These techniques are complementary rather than interchangeable.
It is listed as a prohibited peptide hormone by the World Anti-Doping Agency. No medicines regulator has approved it for human use. Import and sale rules vary by country.
It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.